Silgan Holdings (SLGN)
(Delayed Data from NYSE)
$51.60 USD
-0.39 (-0.75%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $51.60 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$51.60 USD
-0.39 (-0.75%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $51.60 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth D Momentum B VGM
Zacks News
WestRock Hits 52-Week High on Robust Capital Allocation
by Zacks Equity Research
WestRock (WRK) hit a 52-week high of $58.62 on Jul 10.
Greif (GEF) Poised to Grow, Slowdown in China Remains a Drag
by Zacks Equity Research
Greif (GEF) is poised to gain from benefit from sale of non-core assets and strong liquidity position.
Zacks.com featured highlights: Ollie's Bargain Outlet Holdings, Addus HomeCare, Luminex, Silgan Holdings and Two Harbors Investment
by Zacks Equity Research
Zacks.com featured highlights: Ollie's Bargain Outlet Holdings, Addus HomeCare, Luminex, Silgan Holdings and Two Harbors Investment
Avoid Market Volatility with 5 Low-Beta Stocks
by Zacks Equity Research
In this article, we present a strategy which proves that low risky securities can also reap rewards if some specific parameters are considered.
Here's Why Silgan Holdings (SLGN) Be in Your Portfolio Now
by Zacks Equity Research
In this write-up wwe highlight few points why Silgan Holdings, Inc. (SLGN) is a must-add to your portfolio right now.
Silgan (SLGN) Tops Q1 Earnings, Revenues, Lifts '17 EPS View
by Zacks Equity Research
Silgan's (SLGN) first-quarter 2017 earnings beat the Zacks Consensus Estimate.
WestRock (WRK) Beats on Q2 Earnings, Revenue Estimates
by Zacks Equity Research
WestRock Company's (WRK) second-quarter fiscal 2017 adjusted earnings and revenues beat the respective Zacks Consensus Estimate.
WestRock's (WRK) Q2 Earnings, Revenues Beat Estimates
by Zacks Equity Research
WestRock Company's (WRK) second quarter fiscal 2017 earnings and revenues beat the respective Zacks Consensus Estimates.
Silgan (SLGN) Buys WestRock's Dispensing Systems Business
by Zacks Equity Research
Silgan (SLGN) completed the acquisition of WestRock's dispensing systems business for $1.025 billion.
WestRock Sells Home, Health & Beauty Business to Silgan
by Zacks Equity Research
WestRock Company (WRK) has completed the sale of its Home, Health and Beauty business to Silgan Holdings Inc. (SLGN).
Silgan (SLGN) Scales 52-Week High on a Slew of Positives
by Zacks Equity Research
Silgan (SLGN) hit a 52-week high of $61.46 on Mar 20.
Silgan (SLGN) Q4 Earnings Meet Estimates, Revenues Lag
by Zacks Equity Research
Silgan Holdings Inc.'s (SLGN) Q4 adjusted earnings of 48 cents came in line with the Zacks Consensus Estimate while revenues lagged.
Silgan to Buy WestRock's Home, Health & Beauty Business
by Zacks Equity Research
Silgan (SLGN) has entered into a definitive agreement with WestRock to buy its Home, Health and Beauty unit for around $1 billion.
WestRock (WRK) Beats on Q1 Earnings, Bolsters Portfolio
by Zacks Equity Research
WestRock Company's (WRK) first-quarter fiscal 2017 adjusted earnings of 47 cents per share beat the Zacks Consensus Estimate.
WestRock's (WRK) Q1 Earnings Beats, Revenues Lag
by Zacks Equity Research
WestRock Company's (WRK) Q1 fiscal 2017 earnings beat the Zacks Consensus Estimate while revenues missed.